Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 33, pages 1169–1172 (2004)Cite this article

Summary:

Immune-mediated hemolysis is a well-recognized occurrence which complicates the period following a bone marrow transplant (BMT). However, although many studies have investigated the hemolytic anemia following ABO-incompatible BMT, data regarding the occurrence of alloantibodies against red blood cell (RBC) antigens other than ABO in patients undergoing hematopoietic stem cell transplantation are limited. In this review, we briefly analyze the most important non-ABO red blood cell (RBC) antigen systems involved in the development of post-BMT alloimmune hemolytic anemia, paying particular attention to the pathogenic mechanisms and the clinical significance of the alloantibodies involved. Among the non-ABO RBC antigens, RhD antigen is the one most frequently implicated in the development of post-BMT alloimmune hemolytic anemia. Although less frequent than hemolysis following transplants with ABO incompatibility, non-ABO-incompatible allograft hemolysis may severely complicate the post-BMT period creating difficult clinical management issues. For this reason, we advise careful pre-transplant donor and recipient checks for the most important RBC antigen systems and close post-BMT immunohematological monitoring in those patients undergoing allogeneic hematopoietic stem cell transplant with RBC antigen incompatibility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Klumpp TR . Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159–170.

    CAS  PubMed  Google Scholar 

  2. Rowley SD, Liang PS, Ulz L . Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 2000; 26: 749–757.

    Article  CAS  PubMed  Google Scholar 

  3. Ting A, Pun A, Dodds AJ et al. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987; 27: 145–147.

    Article  CAS  PubMed  Google Scholar 

  4. Abou-Elella AA, Camarillo TA, Allen MB et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995; 35: 931–935.

    Article  CAS  PubMed  Google Scholar 

  5. De la Rubia J, Arriaga F, Andreu R et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001; 41: 106–110.

    Article  CAS  PubMed  Google Scholar 

  6. Young PP, Goodnough LT, Westervelt P, DiPersio JF . Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1305–1310.

    Article  CAS  PubMed  Google Scholar 

  7. Hows J, Beddow K, Gordon-Smith EC et al. Donor-derived red cell antibodies and immune hemolysis after allogenic bone marrow transplantation. Blood 1986; 67: 177–181.

    CAS  PubMed  Google Scholar 

  8. Sokol RJ, Stamps R, Booker DJ . Posttransplant immune-mediated hemolysis. Transfusion 2002; 42: 198–204.

    Article  PubMed  Google Scholar 

  9. Friedberg RC . Transfusion therapy in the patients undergoing hematopoietic stem cell transplantation. In: Mintz PD (ed.) Hematology/Oncology Clinics of North America. Transfusion Medicine I. WB Saunders Company: Philadelphia, 1994; pp 1105–1116.

    Google Scholar 

  10. Heim MU, Schleuning M, Eckstein R et al. Rh antibodies against the pretransplant red cells following incompatible bone marrow transplantation. Transfusion 1988; 28: 272–275.

    Article  CAS  PubMed  Google Scholar 

  11. Tasaki T, Sasaki S, Gotoh K et al. Multiple red blood cell antibodies produced by donor B lymphocytes after ABO-matched allogeneic bone marrow transplantation. Transf Sci 1999; 20: 121–127.

    Article  CAS  Google Scholar 

  12. Esteve J, Alcorta I, Pereira A et al. Anti-D antibody of exclusive IgM class after minor Rh(D)-mismatched BMT (letter). Bone Marrow Transplant 1995; 16: 632–633.

    CAS  PubMed  Google Scholar 

  13. Franchini M, de Gironcoli M, Gandini G et al. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT. Bone Marrow Transplant 1998; 21: 1071–1073.

    Article  CAS  PubMed  Google Scholar 

  14. Gandini G, Franchini M, de Gironcoli M et al. Detection of an anti-RhD antibody 2 years after sensitization in a patient who had undergone an allogeneic BMT. Bone Marrow Transplant 2000; 25: 457–459.

    Article  CAS  PubMed  Google Scholar 

  15. Girelli G, Arcese W, Bianchi A et al. Hemolysis in a Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia. Haematologica 1986; 71: 46–49.

    CAS  PubMed  Google Scholar 

  16. Rigal D, Monestier M, Meyer F et al. Transplant of rhesus-positive bone marrow in a rhesus-negative woman having anti-rhesus D alloantibodies. Acta Haematol 1985; 73: 153–156.

    Article  CAS  PubMed  Google Scholar 

  17. Falkenburg JHF, Schaafsma MR, Jansen I et al. Recovery of hematopoiesis after blood-group-incompatible bone marrow transplantation with red-blood-cell-depleted grafts. Transplantation 1984; 39: 514–520.

    Article  Google Scholar 

  18. Heyll A, Aul C, Runde V et al. Treatment of pure red cell aplasia following major ABO incompatible bone marrow transplantation with recombinant erythropoietin (letter). Blood 1991; 77: 906.

    CAS  PubMed  Google Scholar 

  19. Atkinson K . Reconstitution of haemopoietic and immune system after marrow transplantation. Bone Marrow Transplant 1990; 5: 209–226.

    CAS  PubMed  Google Scholar 

  20. McLeod BC, Piehl MR, Sassetti RJ . Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplantation. Vox Sang 1990; 59: 185–189.

    Article  CAS  PubMed  Google Scholar 

  21. Heim MU, Bock M, Kolb HJ et al. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang 1994; 62: 165–168.

    Article  Google Scholar 

  22. Cid J, Ortin X, Elies E et al. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002; 42: 173–176.

    Article  PubMed  Google Scholar 

  23. Molnar R, Johnson R, Sweat LT, Geiger TL . Absence of D alloimmunization in D-pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002; 42: 177–182.

    Article  CAS  PubMed  Google Scholar 

  24. Schonewille H, Haak HL, van Zijl AM . Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999; 39: 763–771.

    Article  CAS  PubMed  Google Scholar 

  25. Lopez A, de la Rubia J, Arriaga F et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998; 38: 247–251.

    Article  CAS  PubMed  Google Scholar 

  26. Myser T, Steedman M, Hunt K et al. A bone marrow transplant with an acquired anti-Lea: a case study. Hum Immunol 1986; 17: 102–106.

    Article  CAS  PubMed  Google Scholar 

  27. Blajchman MA, King DJ, Heddle NM et al. Association of renal failure with Lewis incompatibility after allogeneic bone marrow transplantation. Am J Med 1985; 79: 143–146.

    Article  CAS  PubMed  Google Scholar 

  28. Vassanelli A, Benedetti F, Turrini A et al. Hemolytic anemia due to anti-Kell antibody in bone marrow transplantation [abstract]. Bone Marrow Transplant 1998; 21 (Suppl 1): 331.

    Google Scholar 

  29. Leo A, Mytilineos J, Voso MT et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation. Transfusion 2000; 40: 632–636.

    Article  CAS  PubMed  Google Scholar 

  30. Robertson V, Hill M, Bryant J, Dickson L . Anti-Jkb identified in a Jkb positive recipient following T-cell depleted bone marrow transplant [abstract]. Transfusion 1987; 27: 525.

    Article  Google Scholar 

  31. Oriol R, Le Pendu J, Sparkes RS . Insights into the expression of ABH and Lewis antigens through human bone marrow transplantation. Am J Hum Genet 1981; 33: 551–560.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Izumi N, Fuse I, Furukawa T et al. Long-term production of pre-existing alloantibodies to E and c after allogeneic BMT in a patient with aplastic anemia resulting in a delayed hemolytic anemia. Transfusion 2003; 43: 241–245.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Verona, Italy

    M Franchini, G Gandini & G Aprili

Authors
  1. M Franchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Gandini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Aprili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Franchini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franchini, M., Gandini, G. & Aprili, G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33, 1169–1172 (2004). https://doi.org/10.1038/sj.bmt.1704524

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704524

Keywords

This article is cited by

Search

Advanced search

Quick links